Related Experiment Video
Updated: Dec 18, 2025

08:53
The Arteriovenous AV Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering
Published on: November 2, 2016
12.9K
Arteriogenesis and Therapeutic Angiogenesis in Its Multiple Aspects
Elisabeth Deindl1, Paul H A Quax2
1Walter-Brendel-Centre of Experimental Medicine, University Hospital, Ludwig-Maximilians-University, 81377 Munich, Germany.
Cells
|June 14, 2020
Summary
Arteriogenesis, or collateral formation, is the growth of new blood vessels to bypass blocked arteries. This natural process restores blood flow to tissues, offering therapeutic potential for cardiovascular diseases.
Area of Science:
- Cardiovascular Biology
- Vascular Biology
- Regenerative Medicine
Background:
- Arteriogenesis is the formation and growth of collateral blood vessels.
- These vessels act as natural bypasses, restoring blood flow to tissues supplied by occluded arteries.
- Also known as collateral formation or therapeutic angiogenesis.
Discussion:
- Understanding arteriogenesis is crucial for developing treatments for ischemic diseases.
- Collateral growth can be stimulated to improve blood supply in conditions like peripheral artery disease.
- Research focuses on molecular mechanisms regulating this vital vascular remodeling process.
Key Insights:
- Arteriogenesis involves complex cellular and molecular signaling pathways.
- The process enhances tissue perfusion by creating functional vascular networks.
- It represents a significant endogenous mechanism for recovery from arterial occlusion.
Outlook:
- Therapeutic strategies targeting arteriogenesis hold promise for treating cardiovascular conditions.
- Further research aims to identify novel targets for stimulating collateral vessel growth.
- Harnessing arteriogenesis could revolutionize treatment paradigms for ischemic pathologies.
Related Concept Videos
Mechanism of Angiogenesis
6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Regulation of Angiogenesis and Blood Supply
3.2K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K

